Cargando…
Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines...
Autores principales: | Mamber, Stephen W., Krakowka, Steven, Osborn, Jeffrey, Saberski, Lloyd, Rhodes, Ryan G., Dahlberg, Albert E., Pond-Tor, Sunthorn, Fitzgerald, Kara, Wright, Neal, Beseme, Sarah, McMichael, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227768/ https://www.ncbi.nlm.nih.gov/pubmed/32404512 http://dx.doi.org/10.1128/mSphere.00288-20 |
Ejemplares similares
-
Beyond mineral metabolism, the bright immunomodulatory effect of vitamin D in renal disease
por: Baradaran, Azar
Publicado: (2012) -
Effects of cannabis oil extract on immune response gene expression in human small airway epithelial cells (HSAEpC): implications for chronic obstructive pulmonary disease (COPD)
por: Mamber, Stephen W., et al.
Publicado: (2020) -
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
por: Thomas, Gregory, et al.
Publicado: (2020) -
The Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
por: Mellbye, Brett, et al.
Publicado: (2011) -
Why Do Influenza Virus Subtypes Die Out? A Hypothesis
por: Palese, Peter, et al.
Publicado: (2011)